Integrated Annual Report 2023 2 3 4 5 6 7 8 9 1 327 NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 19. INVESTMENT IN ASSOCIATES (CONTD.) (ii) Summarised statements of comprehensive income Biomedix One Medicare Sedafiat 2023 RM’000 2022 RM’000 2023 RM’000 2022 RM’000 2023 RM’000 2022 RM’000 Revenue 61,397 56,841 218,988 209,260 252,305 251,987 Profit before tax 19,009 21,069 1,825 2,133 7,341 15,295 Profit for the year, representing total comprehensive income 15,288 15,507 1,390 1,457 4,541 10,498 Dividend received from the associates during the year 6,680 1,600 400 - 2,000 3,200 (iii) Reconciliation of the summarised financial information presented above to the carrying amount of the Group’s interest in associates Biomedix One Medicare Sedafiat 2023 RM’000 2022 RM’000 2023 RM’000 2022 RM’000 2023 RM’000 2022 RM’000 Net assets at 1 January 65,100 53,593 34,421 36,464 67,972 65,474 Profit for the year 15,288 15,507 1,390 1,457 4,541 10,498 Dividend from associate (13,500) (4,000) (700) (3,500) (5,000) (8,000) Net assets at 31 December 66,888 65,100 35,111 34,421 67,513 67,972 Interest in associates 40% 40% 40% 40% 40% 40% Carrying value of Group’s interest in material associate 26,755 26,040 14,044 13,768 27,005 27,189
RkJQdWJsaXNoZXIy NDgzMzc=